EDAP nets FDA approval for ultrasound device

The FDA has granted 510(k) marketing clearance to therapeutic ultrasound developer EDAP TMS for its Sonolith I-Sys device.

Sonolith I-Sys is a robotized, integrated lithotripter used to disintegrate urinary stones in association with combined x-ray or ultrasound systems, according to the Lyon, France-based company.

The Sonolith I-Sys received CE mark approval in July 2007 and was launched in the European Union in late 2007.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup